24 November 2017
News and Views
Links and Services
September's issue of the Alimentary Pharmacology & Therapeutics identifies underutilization of gastroprotection for at-risk patients undergoing percutaneous coronary intervention.
Proton pump inhibitors (PPIs) are the preferred agents for the prevention of aspirin-associated u
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors